...
首页> 外文期刊>E3S Web of Conferences >Research on Cervical Cancer and Its Drug Treatment
【24h】

Research on Cervical Cancer and Its Drug Treatment

机译:宫颈癌及其药物治疗研究

获取原文

摘要

Cervical cancer is one of the common malignant tumors in gynecology, usually due to persistent infection with human papillomavirus (HPV). At present, the main therapeutic drugs used in clinical practice are traditional chemotherapeutic drugs and targeted drugs, and drug therapy mainly includes traditional cytotoxic chemotherapy, targeted therapy, immunotherapy. Because traditional chemotherapeutic drugs usually can not solve the problem of drug resistance and side effects, people started using molecular biology and genomics study of targeted drug therapy. This article mainly discusses the target drug treatment of cervical cancer, anti-angiogenesis, immune checkpoint inhibitor treatment methods, as they have been applied in the treatment of cervical cancer and showed effect, which also brought new hope for the treatment of cervical cancer.
机译:宫颈癌是妇科的常见恶性肿瘤之一,通常是由于人乳头瘤病毒(HPV)的持续感染。目前,临床实践中使用的主要治疗药物是传统化学治疗药物和靶向药物,药物治疗主要包括传统的细胞毒性化疗,靶向治疗,免疫疗法。由于传统化学治疗药物通常无法解决耐药性和副作用的问题,人们开始使用分子生物学和基因组学研究靶向药物治疗。本文主要讨论宫颈癌的目标药物治疗,抗血管生成,免疫检查点抑制剂治疗方法,因为它们已被应用于治疗宫颈癌并显示出效果,这也为治疗宫颈癌的新希望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号